Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Buy
673
+7
+1% +$2.4K 0.13% 122
2026
Q1
$234K Hold
666
0.14% 122
2025
Q4
$218K Hold
666
0.13% 134
2025
Q3
$188K Hold
666
0.12% 134
2025
Q2
$186K Sell
666
-21
-3% -$5.95K 0.13% 127
2025
Q1
$214K Hold
687
0.15% 111
2024
Q4
$179K Buy
+687
New +$204K 0.12% 127

Other funds holding AMGN

Millstone Evans Group's AMGN Position: Q2 2026 in Review

Millstone Evans Group increased its Amgen (AMGN) stake by 1.1% in Q2 2026, buying an estimated $2.4K and bringing the position to 673 shares worth $244K. The position accounts for 0.13% of the portfolio, ranked #122.

Millstone Evans Group first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Millstone Evans Group held 673 shares of Amgen worth $244K as of Q2 2026.
  • Millstone Evans Group bought 7 Amgen shares in Q2 2026, an estimated $2.4K.
  • Amgen made up 0.13% of Millstone Evans Group's portfolio in Q2 2026, its #122 holding.
  • Millstone Evans Group first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.